• 1. Department of Huzhou University, School of Nursing Science, Huzhou 313000, P. R. China;
  • 2. Department of Changxing County Hospital of Traditional Chinese Medicine, Changxing 313100, P. R. China;
  • 3. Department of Huzhou University, Huzhou Branch of the Ministry of Education Virtual Research Center of Evidence-Based Medicine, Huzhou 313000, P. R. China;
SHEN Jiantong, Email: 02198@zjhu.edu.cn
Export PDF Favorites Scan Get Citation

The Quality Assessment of Diagnostic Accuracy Studies 2 (QUADAS-2) has been widely accepted in the assessment of diagnostic accuracy and quality. However, it is not suitable for assessing risk of bias in studies comparing diagnostic accuracy. The current common practice in systematic reviews is to derive comparative accuracy from non-comparative diagnostic accuracy studies, which is inherently biased. The QUADAS group developed the QUADAS-Compare (QUADAS-C) tool for assessing the risk of bias in comparative diagnostic accuracy studies. It was officially launched in October 2021. QUADAS-C retains the same 4-domain structure as QUADAS-2: patient selection, index test, reference standard, and flow and timing. It also includes an additional 14 signaling questions and 4 risk of bias questions. This allows researchers to identify high-quality research evidence and avoid bias in research design and conduct. This article interpreted the basic situation, evaluation items, evaluation standards, and usage methods and procedures associated with QUADAS-C to provide references for domestic users.

Citation: HUANG Yuxiang, SHEN Jiantong, LIU Yujin. An introduction to QUADAS-C: a tool for assessing risk of bias in comparative diagnostic accuracy studies. Chinese Journal of Evidence-Based Medicine, 2022, 22(9): 1108-1116. doi: 10.7507/1672-2531.202204090 Copy

Copyright © the editorial department of Chinese Journal of Evidence-Based Medicine of West China Medical Publisher. All rights reserved

  • Previous Article

    Introduction of UK Biobank data application
  • Next Article

    Changes in the disease burden of ischemic stroke in China from 1990 to 2019